Millennium Management »

Bridgebio Pharma shares owned by Millennium Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $849k 500k 1.70

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Bridgebio Pharma

Linden Advisors
D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
Jump Financial
CSS
Alberta Investment Management Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Wellington Management Company
Calamos Advisors
Susquehanna Advisors Group
State Street Corporation

View all funds holding Bridgebio Pharma